AUSTIN, Texas, Aug. 7, 2017 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced financial results for the second quarter of 2017. Financial and operating highlights for the quarter include the following:
Consolidated revenue of $76.5 million, an increase of 19% compared to the second quarter 2016.
Total automated sample to answer molecular product revenue of $10.7 million; pro-forma growth of 44% compared to $7.4 million in the second quarter of 2016.
Consolidated revenue of $76.5 million, an increase of 19% compared to the second quarter 2016.
Total automated sample to answer molecular product revenue of $10.7 million; pro-forma growth of 44% compared to $7.4 million in the second quarter of 2016.
